100 related articles for article (PubMed ID: 28551312)
1. Locally advanced cervical cancer: Is it relevant to report image-guided adaptive brachytherapy using point A dose?
Mazeron R; Gouy S; Escande A; Dumas I; Rivin Del Campo E; Bentivegna E; Bacorro W; Lefkopoulos D; Deutsch E; Morice P; Haie-Meder C; Chargari C
Brachytherapy; 2017; 16(4):862-869. PubMed ID: 28551312
[TBL] [Abstract][Full Text] [Related]
2. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.
Tanderup K; Fokdal LU; Sturdza A; Haie-Meder C; Mazeron R; van Limbergen E; Jürgenliemk-Schulz I; Petric P; Hoskin P; Dörr W; Bentzen SM; Kirisits C; Lindegaard JC; Pötter R
Radiother Oncol; 2016 Sep; 120(3):441-446. PubMed ID: 27350396
[TBL] [Abstract][Full Text] [Related]
3. Tumor dose-volume response in image-guided adaptive brachytherapy for cervical cancer: A meta-regression analysis.
Mazeron R; Castelnau-Marchand P; Escande A; Rivin Del Campo E; Maroun P; Lefkopoulos D; Chargari C; Haie-Meder C
Brachytherapy; 2016; 15(5):537-42. PubMed ID: 27371991
[TBL] [Abstract][Full Text] [Related]
4. Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: Clinical outcome and prognostic factors.
Ka K; Laville A; Rassy E; Ayachi RE; Pautier P; Ba MB; Bockel S; Achkar S; Espenel S; Maulard A; Morice P; Gouy S; Haie-Meder C; Sun R; Chargari C
Gynecol Oncol; 2023 Jan; 168():32-38. PubMed ID: 36370612
[TBL] [Abstract][Full Text] [Related]
5. A volumetric analysis of GTV
Jastaniyah N; Yoshida K; Tanderup K; Lindegaard JC; Sturdza A; Kirisits C; Šegedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz IM; Haie-Meder C; Banerjee S; Pötter R;
Radiother Oncol; 2016 Sep; 120(3):404-411. PubMed ID: 27452409
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer.
Castelnau-Marchand P; Chargari C; Maroun P; Dumas I; Del Campo ER; Cao K; Petit C; Martinetti F; Tafo-Guemnie A; Lefkopoulos D; Morice P; Haie-Meder C; Mazeron R
Gynecol Oncol; 2015 Nov; 139(2):288-94. PubMed ID: 26364808
[TBL] [Abstract][Full Text] [Related]
7. Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy.
Mazeron R; Castelnau-Marchand P; Dumas I; del Campo ER; Kom LK; Martinetti F; Farha G; Tailleur A; Morice P; Chargari C; Lefkopoulos D; Haie-Meder C
Radiother Oncol; 2015 Feb; 114(2):257-63. PubMed ID: 25497872
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted MRI in image-guided adaptive brachytherapy: Tumor delineation feasibility study and comparison with GEC-ESTRO guidelines.
Schernberg A; Balleyguier C; Dumas I; Gouy S; Escande A; Bentivegna E; Morice P; Deutsch E; Haie-Meder C; Chargari C
Brachytherapy; 2017; 16(5):956-963. PubMed ID: 28673762
[TBL] [Abstract][Full Text] [Related]
9. MRI-guided high-dose-rate intracavitary brachytherapy for treatment of cervical cancer: the University of Pittsburgh experience.
Gill BS; Kim H; Houser CJ; Kelley JL; Sukumvanich P; Edwards RP; Comerci JT; Olawaiye AB; Huang M; Courtney-Brooks M; Beriwal S
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):540-7. PubMed ID: 25680598
[TBL] [Abstract][Full Text] [Related]
10. Dose-effect relationship between dose-volume parameters of residual gross tumor volume and clinical prognosis in MRI-guided adaptive brachytherapy for locally advanced cervical cancer: a single-center retrospective study.
Ke T; Wang J; Zhang N; Zhao H; Guo X; Zhao Z; Mao Z; Cheng G
Strahlenther Onkol; 2023 Feb; 199(2):131-140. PubMed ID: 36109399
[TBL] [Abstract][Full Text] [Related]
11. Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results.
Dimopoulos JC; Schmid MP; Fidarova E; Berger D; Kirisits C; Pötter R
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1880-8. PubMed ID: 21868174
[TBL] [Abstract][Full Text] [Related]
12. Post radiation hysterectomy in locally advanced cervical cancer: Outcomes and dosimetric impact.
Mazeron R; Gouy S; Chargari C; Rivin Del Campo E; Dumas I; Mervoyer A; Genestie C; Bentivegna E; Balleyguier C; Pautier P; Morice P; Haie-Meder C
Radiother Oncol; 2016 Sep; 120(3):460-466. PubMed ID: 27492204
[TBL] [Abstract][Full Text] [Related]
13. Image-guided adaptive brachytherapy in primary vaginal cancers: A monocentric experience.
Huertas A; Dumas I; Escande A; Rivin Del Campo E; Felefly T; Canova CH; Tailleur A; Gouy S; Bentivegna E; Morice P; Haie-Meder C; Chargari C; Mazeron R
Brachytherapy; 2018; 17(3):571-579. PubMed ID: 29426746
[TBL] [Abstract][Full Text] [Related]
14. Characterization of combined intracavitary/interstitial brachytherapy including oblique needles in locally advanced cervix cancer.
Serban M; Fokdal L; Nielsen SK; Hokland SB; Hansen AT; Spejlborg H; Rylander S; Petric P; Lindegaard JC; Tanderup K
Brachytherapy; 2021; 20(4):796-806. PubMed ID: 33994344
[TBL] [Abstract][Full Text] [Related]
15. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.
Dimopoulos JC; Lang S; Kirisits C; Fidarova EF; Berger D; Georg P; Dörr W; Pötter R
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):56-63. PubMed ID: 19289267
[TBL] [Abstract][Full Text] [Related]
16. Safe dose escalation and reduction of the fraction number of uterine cervical brachytherapy using a gel spacer in the rectovaginal and vesicouterine septum: A planning study.
Takatsu J; Murakami N; Muramoto Y; Karino T; Oshima M; Kosugi Y; Kawamoto T; Terao Y; Shikama N
Brachytherapy; 2024; 23(2):115-122. PubMed ID: 38040605
[TBL] [Abstract][Full Text] [Related]
17. Impact of different dose prescription schedules on EQD
Kumar M; Thangaraj R; Alva RC; Koushik K; Ponni A; Achar JM
J Contemp Brachytherapy; 2019 Apr; 11(2):189-193. PubMed ID: 31139229
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric analysis of 3D image-guided HDR brachytherapy planning for the treatment of cervical cancer: is point A-based dose prescription still valid in image-guided brachytherapy?
Kim H; Beriwal S; Houser C; Huq MS
Med Dosim; 2011; 36(2):166-70. PubMed ID: 20488690
[TBL] [Abstract][Full Text] [Related]
19. Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study.
Mazeron R; Fokdal LU; Kirchheiner K; Georg P; Jastaniyah N; Šegedin B; Mahantshetty U; Hoskin P; Jürgenliemk-Schulz I; Kirisits C; Lindegaard JC; Dörr W; Haie-Meder C; Tanderup K; Pötter R;
Radiother Oncol; 2016 Sep; 120(3):412-419. PubMed ID: 27396811
[TBL] [Abstract][Full Text] [Related]
20. Hybrid TRUS/CT with optical tracking for target delineation in image-guided adaptive brachytherapy for cervical cancer.
Smet S; Nesvacil N; Knoth J; Sturdza A; Najjari-Jamal D; Jelinek F; Kronreif G; Pötter R; Widder J; Kirisits C; Schmid MP
Strahlenther Onkol; 2020 Nov; 196(11):983-992. PubMed ID: 32621011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
